A randomized control trial with a sample size of 30 in each group. After getting the approval from the institution ethics committee, patients who satisfy the inclusion criteria and exclusion criteria will be included in the study. All patients will be admitted and a detailed history, relevant clinical examination and relevant investigations will be done. After establishing the diagnosis, the patients will be subjected to Laparoscopic cholecystectomy. After obtaining consent, Patients will be randomly allotted into blocks and separated into control group  and test group. Patients in test group will receive  20 ml of 0.25% BUPIVACAINE administered via cannula into the region of gallbladder bed after the gallbladder is dissected. The patients in control group will not receive any medications intraoperatively. Both the groups will be assessed with visual analogue pain scale with a score of 0-10 at 0 hr, 2 hr, 4 hr, 6 hr and at 12 hours post surgery. Patients will be prescribed INJ. TRAMADOL 50mg intravenous sos. Drug utilization will be reviewed at 24 hours. Time taken to start mobilizing and duration of stay are noted. Pain score, analgesic usage, postoperative nausea, time to mobilize and duration of stay are compared between the two groups and analyzed.